Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 30
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 


 
 Table of Contents  
REVIEW ARTICLE
Year : 2010  |  Volume : 1  |  Issue : 2  |  Page : 182-189

A new generation of 7-Chloro-4-Aminoquinoline antimalarials


1 Department of Pharmaceutical Chemistry, Geetanjali College of Pharmaceutical Studies, Udaipur, Rajasthan, India
2 Department of Pharmaceutical Chemistry, Jaipur National University, Jaipur, Rajasthan, India
3 Department of Pharmaceutical Chemistry, B. N. P. G. College, Udaipur, Rajasthan, India
4 Department of Pharmaceutical Chemistry, IES School of Pharmacy, Bhopal, Madhya Pradesh, India

Date of Submission21-Oct-2009
Date of Acceptance27-Oct-2009
Date of Web Publication7-Jan-2011

Correspondence Address:
V Singh
Department of Pharmaceutical Chemistry, Geetanjali College of Pharmaceutical Studies, Udaipur, Rajasthan
India
Login to access the Email id


DOI: 10.4103/0975-8453.75081

Get Permissions

  Abstract 

There is an urgent need to find new and cost-effective drug molecules for the treatment of malaria due to the rapid spread of resistance toward currently available drugs. Records of malaria date back to the earliest human civilizations when it was described as the distinct periodic fevers. Malaria is a serious infection with Plasmodium parasites, which are spread by the bite of Anopheles mosquitoes. For this reason, nearly all malaria control strategies target either the parasite or the mosquito. In spite of worldwide efforts, however, an eradication of malaria is far from being achieved. There are no fewer than 4 species of Plasmodium that infect people, each with thousands of genetic variants, and about -35 different species of malaria-transmitting mosquitoes. It is the complex diversity of the parasites, the mosquitoes, the local ecologies, socioeconomic conditions, and human responses to disease that conspire to make malaria notoriously hard to control. There is no single prescription which can successfully control malaria in all areas. Plasmodium falciparum is generally slow to develop resistance to the 4-aminoquinoline-containing drug. Antimalarial drug resistance is worsening, with the geographic spread of resistance widening to previously unaffected areas and a remorseless increase both in the prevalence and degree of drug resistance. The unavoidable spread of drug resistance and until the development of an effective antimalarial vaccine, the search for effective, safe, and affordable drugs for falciparum malaria is one of the most pressing health priorities worldwide. This article reviews the newly synthesized 7-chloro-4-aminoquinolines as effective antimalarial agents.

Keywords: Malaria, Plasmodium falciparum, Antimalarial agents, 4-aminoquinoline


How to cite this article:
Singh V, Tyagi L, Singhal M, Sharma C S, Kori M L. A new generation of 7-Chloro-4-Aminoquinoline antimalarials. Syst Rev Pharm 2010;1:182-9

How to cite this URL:
Singh V, Tyagi L, Singhal M, Sharma C S, Kori M L. A new generation of 7-Chloro-4-Aminoquinoline antimalarials. Syst Rev Pharm [serial online] 2010 [cited 2013 May 25];1:182-9. Available from: http://www.sysrevpharm.org/text.asp?2010/1/2/182/75081

This Article is Retracted







 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
Abstract

 Article Access Statistics
    Viewed992    
    Printed143    
    Emailed1    
    PDF Downloaded2    
    Comments [Add]    

Recommend this journal